Noonan G - Search Results

1

Montelukast dose selection in 6- to 14-year-olds: comparison of single-dose pharmacokinetics in children and adults.

Knorr B, Larson P, Nguyen HH, Holland S, Reiss TF, Chervinsky P, Blake K, van Nispen CH, Noonan G, Freeman A, Haesen R, Michiels N, Rogers JD, Amin RD, Zhao J, Xu X, Seidenberg BC, Gertz BJ, Spielberg S. Knorr B, et al. Among authors: noonan g. J Clin Pharmacol. 1999 Aug;39(8):786-93. doi: 10.1177/00912709922008434. J Clin Pharmacol. 1999. PMID: 10434229 Clinical Trial.

2

Effect of montelukast, a once-daily leukotriene receptor antagonist, on peak expiratory flow variability.

Zhang J, Yu C, Noonan G, Reiss TF. Zhang J, et al. Among authors: noonan g. Clin Ther. 2002 Apr;24(4):574-82. doi: 10.1016/s0149-2918(02)85133-5. Clin Ther. 2002. PMID: 12017402

3

Long-term asthma control with oral montelukast and inhaled beclomethasone for adults and children 6 years and older.

Williams B, Noonan G, Reiss TF, Knorr B, Guerra J, White R, Matz J. Williams B, et al. Among authors: noonan g. Clin Exp Allergy. 2001 Jun;31(6):845-54. doi: 10.1046/j.1365-2222.2001.01085.x. Clin Exp Allergy. 2001. PMID: 11422148 Clinical Trial.

4

Effects of montelukast (MK-0476), a new potent cysteinyl leukotriene (LTD4) receptor antagonist, in patients with chronic asthma.

Reiss TF, Altman LC, Chervinsky P, Bewtra A, Stricker WE, Noonan GP, Kundu S, Zhang J. Reiss TF, et al. Among authors: noonan gp. J Allergy Clin Immunol. 1996 Sep;98(3):528-34. doi: 10.1016/s0091-6749(96)70086-6. J Allergy Clin Immunol. 1996. PMID: 8828530 Clinical Trial.

5

Use of oral montelukast in the treatment of asthma.

Noonan GP, Williams B, Angner R, Lu S, Knorr B, Reiss TF. Noonan GP, et al. Compr Ther. 2001 Summer;27(2):148-55. doi: 10.1007/s12019-996-0010-9. Compr Ther. 2001. PMID: 11430263 Review.

6

Reports of suicidality in clinical trials of montelukast.

Philip G, Hustad C, Noonan G, Malice MP, Ezekowitz A, Reiss TF, Knorr B. Philip G, et al. Among authors: noonan g. J Allergy Clin Immunol. 2009 Oct;124(4):691-6.e6. doi: 10.1016/j.jaci.2009.08.010. J Allergy Clin Immunol. 2009. PMID: 19815114

7

Analysis of behavior-related adverse experiences in clinical trials of montelukast.

Philip G, Hustad CM, Malice MP, Noonan G, Ezekowitz A, Reiss TF, Knorr B. Philip G, et al. Among authors: noonan g. J Allergy Clin Immunol. 2009 Oct;124(4):699-706.e8. doi: 10.1016/j.jaci.2009.08.011. J Allergy Clin Immunol. 2009. PMID: 19815116

8

Clinical safety and tolerability of montelukast, a leukotriene receptor antagonist, in controlled clinical trials in patients aged > or = 6 years.

Storms W, Michele TM, Knorr B, Noonan G, Shapiro G, Zhang J, Shingo S, Reiss TF. Storms W, et al. Among authors: noonan g. Clin Exp Allergy. 2001 Jan;31(1):77-87. doi: 10.1046/j.1365-2222.2001.00969.x. Clin Exp Allergy. 2001. PMID: 11167954

9

Airway obstruction lability helps distinguish levels of disease activity in asthma.

Greenberg S, Liu N, Kaur A, Lakshminarayanan M, Zhou Y, Nelsen LM, Smugar SS, Noonan G, Reiss TF, Knorr BA. Greenberg S, et al. Among authors: noonan g. Respir Med. 2012 Apr;106(4):500-7. doi: 10.1016/j.rmed.2011.12.013. Epub 2012 Jan 31. Respir Med. 2012. PMID: 22301379 Free article.

10

Safety and tolerability of montelukast in placebo-controlled pediatric studies and their open-label extensions.

Bisgaard H, Skoner D, Boza ML, Tozzi CA, Newcomb K, Reiss TF, Knorr B, Noonan G. Bisgaard H, et al. Among authors: noonan g. Pediatr Pulmonol. 2009 Jun;44(6):568-79. doi: 10.1002/ppul.21018. Pediatr Pulmonol. 2009. PMID: 19449366 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

103 results

Search Page

Filters